These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1858470)

  • 1. [The dynamics of the morphological changes in the tissues after the subcutaneous administration of vaccines against Q fever].
    Resl M; Vasilenko AZh; Lesný M; Propper P
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):40-3. PubMed ID: 1858470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactogenic activity of C. burneti vaccines. I. Allergenic and toxic properties of phases I and II C. burneti corpuscular vaccines].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):665-78. PubMed ID: 5742338
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
    Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with simultaneous immunization of the population with live vaccines against brucellosis and Q-fever].
    Kniazeva EN; Genig VA; Beletskaia GA; Voshchakina NV; Egorova LS; Kostiukov VL; Panina NV; Tsel'nikov PS
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):112-7. PubMed ID: 5787559
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenic value of various phase I Q vaccines prepared from various strains of Coxiella burneti].
    Zarnea G; Crăcea E; Dumitresco S; Novac S; Mihancea N
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):691-6. PubMed ID: 5742340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reactogenic activity of C. burneti vaccines. II. Attempts to separate the protecting potency from the toxic and allergenic effects of phase I C. burneti vaccine].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):679-90. PubMed ID: 5742339
    [No Abstract]   [Full Text] [Related]  

  • 7. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.
    ORMSBEE RA; BELL EJ; LACKMAN DB; TALLENT G
    J Immunol; 1964 Mar; 92():404-12. PubMed ID: 14128986
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of phase 1Q fever antigen suitable for vaccine use.
    Spicer DS; DeSanctis AN
    Appl Environ Microbiol; 1976 Jul; 32(1):85-8. PubMed ID: 970938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.
    Wachter RF; Briggs GP; Pedersen CE
    Infect Immun; 1978 Nov; 22(2):627-8. PubMed ID: 730378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the immunogenicity of various phases of the Burneti rickettsia].
    Kudelina RI; Fedorova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):17-21. PubMed ID: 5617968
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of local morphological changes after intradermal inoculation of Q-fever chemovaccine.
    Resl M; Sidorenko SV; Zhuljabin EI
    Acta Virol; 1989 Mar; 33(2):167-71. PubMed ID: 2569813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti.
    Robinson DM; Hasty SE
    Appl Microbiol; 1974 Apr; 27(4):777-83. PubMed ID: 4825980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antigenic structure of vaccinal strain M-44 of Burnet's rickettsia].
    Pautov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):139. PubMed ID: 4787688
    [No Abstract]   [Full Text] [Related]  

  • 15. [Humoral immune response of goats, rabbits and guinea pigs following vaccination with a Q fever vaccine].
    Schmeer N; Adami M; Döpfer B; Herbst W; Schmuck W
    Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):20-4. PubMed ID: 3985935
    [No Abstract]   [Full Text] [Related]  

  • 16. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM; England MJ; Pitt ML
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitation of phase I antigen of Coxiella burnetii by sodium sulfite.
    Wachter RF; Briggs GP; Pedersen CE
    Acta Virol; 1975 Nov; 19(6):500. PubMed ID: 2000
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia.
    Kazár J; Brezina R; Palanová A; Tvrdá B; Schramek S
    Bull World Health Organ; 1982; 60(3):389-94. PubMed ID: 6982774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.